Skip to main navigation
Logo
  • ABOUT
    • Corporate Overview
    • History
    • Executive Team
    • Board of Directors
    • Collaborations
    • Contact
  • PRODUCTS
    • Glatopa
    • Enoxaparin
  • PIPELINE
    • Pipeline
    • Biosimilars
      • Strategy
      • Development Program
    • Novel Products
      • Autoimmune Indications
    • Complex Generics
      • M356
  • TECHNOLOGY
    • Momenta Advantage
    • Intellectual Property
  • INVESTORS

    Investor Relations

    • Overview
    • Stock Information
      • Overview
      • Historic Stock Lookup
      • Analyst Coverage
    • Financials & Filings
      • Overview
      • SEC Filings
      • Annuals and Proxies
      • Quarterly Results
      • Key Ratios
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Overview
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Investor FAQs
    • Email and News Alerts
    • Contact Us
  • NEWS & PUBLICATIONS
    • News
    • Publications
  • CAREERS

Investors

Investors • SC 13G

SEC Filing Details

Document Details

Form
SC 13G
Filing Date
Feb 14, 2005
Document Date
Feb 14, 2005
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
3,4,5
Company
Momenta Pharmaceuticals
Issuer
MOMENTA PHARMACEUTICALS INC

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Shareholder Tools

  • Printed Materials
  • Email Alerts
  • Downloads
  • RSS
  • Print

Momenta® and the Momenta logo are registered trademarks of Momenta Pharmaceuticals, Inc.
© 2019 Momenta Pharmaceuticals - All Rights Reserved | Terms of Use | Privacy